Investor Relations
Investor Relations
Webcast Recording for Annual Shareholders Meeting – May 23, 2013
Analyst Coverage
CEOLIVE Investor Insight Series Featuring InVivo Therapeutics
Latest News
- InVivo Therapeutics’ Frank Reynolds Named a ‘CFO of the Year’ Finalist by Boston Business Journal
- InVivo Therapeutics Raises $16.1 Million from Warrant Call and Exercises Paving Way for Up-Listing to a National Securities Exchange
- CORRECTING and REPLACING InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to be held on May 23rd
- Interview with InVivo Therapeutics’ CEO to be Aired on Boston’s NPR Station WBUR This Morning
- InVivo Therapeutics Announces Webcast for Annual Shareholders Meeting to be held on May 23th
- InVivo Therapeutics Sponsors 8th Annual Working 2 Walk Spinal Cord Injury Symposium
- InVivo Therapeutics Reports First Quarter 2013 Financial Results, Provides Business Update
- InVivo Therapeutics Announces Call Notice for Exercise of Warrants and Partial Termination of Warrant Exchange Offer
- InVivo Therapeutics Named a 2013 “Best Places to Work” Winner by Boston Business Journal
- InVivo Therapeutics’ CEO Scheduled to Appear on FOX Business Network’s “Varney & Company”
- InVivo Therapeutics’ CEO Scheduled to Appear on Business News Network’s “The Close” in Canada
- InVivo Enters Commercialization Phase, Adds John A. McCarthy to Board of Directors
- InVivo Therapeutics’ CEO Scheduled to Appear on WCVB-TV in Boston Tonight
- InVivo Therapeutics Announces Warrant Exchange Offer with Intent to Up-List to a National Securities Exchange
- InVivo Therapeutics Receives Approval from FDA for First Human Trial Using Biomaterials for Traumatic Spinal Cord Injury
- InVivo Therapeutics Receives Humanitarian Use Device Designation for Spinal Cord Injury Treatment
- InVivo Therapeutics Sponsors 2013 RISE Above Paralysis Gala
- InVivo Therapeutics Reports 2012 Financial Results, Provides Business Update
- InVivo Therapeutics Submits Updated IDE to FDA to Begin Spinal Cord Injury Human Study
- InVivo Therapeutics Calls for Papers for 2nd Annual Langer Summit on Neurotrauma
- InVivo Therapeutics to Present at 5th Annual Biotech Showcase
- InVivo Therapeutics Co-Founder Robert S. Langer to be Awarded National Medal of Technology and Innovation by President Barack Obama at the White House in Early 2013
- InVivo’s Jason Fowler Wins 2012 Ironman World Championship
- Biogen Executive Kenneth DiPietro Joins InVivo Therapeutics Board of Directors
- InVivo Therapeutics Requests Humanitarian Use Device Designation with FDA
- InVivo Therapeutics Reports Third Quarter 2012 Financial Results, Provides Business Update
- InVivo Therapeutics to Present at Lazard Capital Markets 9th Annual Healthcare Conference
- Dr. Alex Aimetti of InVivo Therapeutics to Speak at Working 2 Walk Spinal Cord Injury Symposium
- InVivo Therapeutics Releases Letter to Shareholders
- InVivo Therapeutics Awarded $2 Million Loan from MassDevelopment
- InVivo Therapeutics Names Veteran Biomaterials Expert Bill D’Agostino as Senior Director of Manufacturing & Engineering
- InVivo to Present at 2012 Aegis Healthcare Conference
Stock Chart
2011 Annual Report
2012 Annual Shareholders Meeting
To participate in the webcast, click the following link: